Skip to content
Menu

Novozymes A/S NVZMY

Full chart Compare
Set alert

Price alert · NVZMY

All alert types
64.39 USD -0.27 (-0.42%)

Regular-session close

64.29 Day range 64.98
49.90 52-week range 75.27
YTD
+1.21%
1 year
+6.77%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

24.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E 300×
P/S 40.3×
P/B 15.4×
P/FCF 223×
EV/EBITDA 137×
EV/Sales 45.7×
FCF Yield 0.4%

Profitability

Gross Margin 53.9%
Operating Margin 21.2%
Net Margin 14.0%
ROE 5.4%
ROIC 4.6%
ROA 3.6%

Growth (YoY)

Revenue 709.4%
Operating Income 33.0%
EPS (diluted) 733.3%
Free Cash Flow 13.7%

Financial Health

Current Ratio 0.7×
Quick Ratio 0.4×
Debt / Equity 2.1×
Net Debt / EBITDA 16.0×
Interest Coverage 96.6×

Dividends

Dividend Yield 0.2%
Payout Ratio 69.0%

Annual · latest fiscal year ends 2025-12-31